Cargando…
Neglected Disease Research and Development: How Much Are We Really Spending?
Mary Moran and colleagues survey global investment into research and development of new pharmaceutical products to prevent, manage, or cure diseases of the developing world.
Autores principales: | Moran, Mary, Guzman, Javier, Ropars, Anne-Laure, McDonald, Alina, Jameson, Nicole, Omune, Brenda, Ryan, Sam, Wu, Lindsey |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634791/ https://www.ncbi.nlm.nih.gov/pubmed/19192946 http://dx.doi.org/10.1371/journal.pmed.1000030 |
Ejemplares similares
-
What Drives Health-Care Spending Priorities? An International Survey of Health-Care Professionals
por: Salkeld, Glenn, et al.
Publicado: (2007) -
Who Should Pay for Global Health, and How Much?
por: Carrasco, Luis R., et al.
Publicado: (2013) -
Is the Current Management of Severe Sepsis and Septic Shock Really Evidence Based?
por: Vincent, Jean-Louis
Publicado: (2006) -
Registering New Drugs for Low-Income Countries: The African
Challenge
por: Moran, Mary, et al.
Publicado: (2011) -
Addressing the Global Neglect of Childhood Hearing Impairment in Developing Countries
por: Olusanya, Bolajoko O
Publicado: (2007)